Skip to main content
Poll: Impact of HCV Treatment Among Injection Drug Users
Menu
Menu
Main navigation
Home
Education
Featured Diseases & Conditions
Acute Myeloid Leukemia
Alzheimer Disease
Breast Cancer
COVID-19
Depression Care 360
Diabetes Technology
Digital Health Solutions in Diabetes
Endovascular
HER2-Positive Early Breast Cancer
HIV Management
HIV Prevention
Merkel Cell Carcinoma
Ovarian Cancer
Primary Hyperoxaluria
Psoriatic Arthritis
Women's Health
Vaccines
Resources
Atlas of Lumps and Bumps
Case Presentations
Commentary
Disease State and Specialty Directory
FDA Alerts
Pearls
Podcasts
Polls
Q&A
Quizzes
Research Summaries
Slideshows
Videos
Featured Conferences
ACR Convergence
AIBD
American Heart Association Scientific Sessions
American Society of Hematology Annual Meeting & Exposition
Consultant360's Practical Updates in Primary Care
Conference on Retroviruses and Opportunistic Infections
Infectious Diseases Society of America’s IDWeek
International AIDS Conference
Society of Hematologic Oncology's Annual Meeting
Clinical Updates
Allergic Asthma
Alzheimer Disease
Cardiovascular Disease
Endometrial Cancer
Endometriosis
Eosinophilic Disorders
Exocrine Pancreatic Insufficiency
Generalized Pustular Psoriasis
Major Depressive Disorder
Nasal Polyps
Ovarian Cancer
Rheumatoid Arthritis
Schizophrenia
Ulcerative Colitis
Publication
About Consultant
Advertising With Consultant360
Consultant Current Issue
Consultant Archive
Author Guidelines
Consultant Early View
Case Report Templates
FAQ
Job Board
Search
Contact
Login
Menu
Menu
Main navigation
Home
Education
Featured Diseases & Conditions
Acute Myeloid Leukemia
Alzheimer Disease
Breast Cancer
COVID-19
Depression Care 360
Diabetes Technology
Digital Health Solutions in Diabetes
Endovascular
HER2-Positive Early Breast Cancer
HIV Management
HIV Prevention
Merkel Cell Carcinoma
Ovarian Cancer
Primary Hyperoxaluria
Psoriatic Arthritis
Women's Health
Vaccines
Resources
Atlas of Lumps and Bumps
Case Presentations
Commentary
Disease State and Specialty Directory
FDA Alerts
Pearls
Podcasts
Polls
Q&A
Quizzes
Research Summaries
Slideshows
Videos
Featured Conferences
ACR Convergence
AIBD
American Heart Association Scientific Sessions
American Society of Hematology Annual Meeting & Exposition
Consultant360's Practical Updates in Primary Care
Conference on Retroviruses and Opportunistic Infections
Infectious Diseases Society of America’s IDWeek
International AIDS Conference
Society of Hematologic Oncology's Annual Meeting
Clinical Updates
Allergic Asthma
Alzheimer Disease
Cardiovascular Disease
Endometrial Cancer
Endometriosis
Eosinophilic Disorders
Exocrine Pancreatic Insufficiency
Generalized Pustular Psoriasis
Major Depressive Disorder
Nasal Polyps
Ovarian Cancer
Rheumatoid Arthritis
Schizophrenia
Ulcerative Colitis
Publication
About Consultant
Advertising With Consultant360
Consultant Current Issue
Consultant Archive
Author Guidelines
Consultant Early View
Case Report Templates
FAQ
Job Board
Advertisement
Health Outcomes
Poll: Impact of HCV Treatment Among Injection Drug Users
Copied to clipboard
Hepatitis C virus (HCV) is common among individuals who inject drugs, and treatment options are now available to this population. A
recent survey
of individuals with HCV who inject drugs aimed to highlight the nonclinical impacts of HCV treatment. Have you found any of the following areas have been improved in your patients receiving HCV treatment?
Outlook for the future
Self-esteem
Ability to plan for the future
Belief in their abilities
Confidence
Empowerment
Energy levels
Ability to look after themselves
advertisement
Advertisement
Advertisement